AAAAAA
Results:
1-9
|
Results: 9
Authors:
Peuskens, J
De Hert, M
Jones, M
Citation: J. Peuskens et al., The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety, INT J PSYC, 5(3), 2001, pp. 179-187
Can we identify the factors influencing the burden on family members of patients with schizophrenia?
Authors:
Lowyck, B
De Hert, M
Peeters, E
Gilis, P
Peuskens, J
Citation: B. Lowyck et al., Can we identify the factors influencing the burden on family members of patients with schizophrenia?, INT J PSYC, 5(2), 2001, pp. 89-96
Authors:
De Hert, M
McKenzie, K
Peuskens, J
Citation: M. De Hert et al., Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study, SCHIZOPHR R, 47(2-3), 2001, pp. 127-134
Authors:
Peuskens, J
Van Baelen, B
De Smedt, C
Lemmens, P
Citation: J. Peuskens et al., Effects of risperidone on affective symptoms in patients with schizophrenia, INT CLIN PS, 15(6), 2000, pp. 343-349
Authors:
Peuskens, J
Citation: J. Peuskens, Switching approach in the management of schizophrenia patients, INT CLIN PS, 15, 2000, pp. S15-S19
Authors:
Peuskens, J
Citation: J. Peuskens, Amisulpride: its role in the therapeutic management of the schizophrenic patient - Proceedings from the Sanofi-Synthelabo Satellite Symposium held atthe Ninth Congress of the Association of European Psychiatrists in Copenhagen, Denmark 1998 - Conclusions, ACT PSYC SC, 101, 2000, pp. 28-29
Authors:
Peuskens, J
Bech, P
Moller, HJ
Bale, R
Fleurot, O
Rein, W
Citation: J. Peuskens et al., Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia, PSYCHIAT R, 88(2), 1999, pp. 107-117
Authors:
Peuskens, J
Citation: J. Peuskens, The evolving definition of treatment resistance, J CLIN PSY, 60, 1999, pp. 4-8
Authors:
De Hert, M
Thys, E
Boydens, J
Gilis, P
Kesteloot, K
Verhaegen, L
Peuskens, J
Citation: M. De Hert et al., Health care expenditure on schizophrenia patients in Belgium, SCHIZO BULL, 24(4), 1998, pp. 519-527
Risultati:
1-9
|